Yasmine O Elshenawi

Mrs. Yasmine O Elshenawi

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
YEYasmine O Elshenawi
Yasmine O Elshenawi
SHShuai Hu
Shuai Hu
SHSkander Hathroubi
Skander Hathroubi
Helicobacter pylori is a gastric pathogen that infects nearly half of the global population and is recognized as a group 1 carcinogen by the Word Health Organization. The global rise in antibiotic resistance has increased clinical challenges in treating H. pylori infections. Biofilm growth has been proposed to contribute to H. pylori’s chronic colonization of the host stomach, treatment failures, and the eventual development of gastric diseases. Several components of H. pylori have been identified to promote biofilm growth, and several of these may also facilitate antibiotic tolerance, including the extracellular matrix, outer membrane proteins, shifted morphology, modulated metabolism, efflux pumps, and virulence factors. Recent developments in therapeutic approaches targeting H. pylori biofilm have shown that synthetic compounds, such as small molecule drugs and plant-derived compounds, are effective at eradicating H. pylori biofilms. These combined topics highlight the necessity for biofilm-based research in H. pylori, to improve current H. pylori-targeted therapeutic approaches and alleviate relative public health burden. In this review we discuss recent discoveries that have decoded the life cycle of H. pylori biofilms and current biofilm-targeted treatment strategies.

30 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
YEYasmine O Elshenawi
Yasmine O Elshenawi
SHShuai Hu
Shuai Hu
SHSkander Hathroubi
Skander Hathroubi
Helicobacter pylori is a gastric pathogen that infects nearly half of the global population and is recognized as a group 1 carcinogen by the Word Health Organization. The global rise in antibiotic resistance has increased clinical challenges in treating H. pylori infections. Biofilm growth has been proposed to contribute to H. pylori’s chronic colonization of the host stomach, treatment failures, and the eventual development of gastric diseases. Several components of H. pylori have been identified to promote biofilm growth, and several of these may also facilitate antibiotic tolerance, including the extracellular matrix, outer membrane proteins, the coccoid morphology, modulated metabolism, efflux pumps, and virulence factors. Recent developments in therapeutic approaches targeting H. pylori biofilm have shown that synthetic compounds, such as small molecule drugs and plant-derived compounds, are effective at eradicating H. pylori biofilms. These combined topics highlight the necessity for biofilm-based research in H. pylori, to improve current H. pylori targeted therapeutic approaches and alleviate relative public health burden. In this review we discuss recent discoveries that have decoded the life cycle of H. pylori biofilms and current biofilm targeted treatment strategies.

7 May 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
YEYasmine O Elshenawi
Yasmine O Elshenawi
SHSkander Hathroubi
Skander Hathroubi
SHShuai Hu
Shuai Hu
Xiaolin LiuXiaolin Liu
Xiaolin Liu
KOKaren M. Ottemann
Karen M. Ottemann
Helicobacter pylori is a motile bacterial pathogen that causes severe gastric diseases. H. pylori motility and chemotaxis are key colonization factors. Motility and chemotaxis are studied in many microbes, including H. pylori, using soft agar assays. In these assays, bacteria are inoculated into low-percentage agar and expand in a motility- and chemotaxis-dependent manner. H. pylori similarly expands in soft agar, but, if a plate was inoculated at multiple points, the expanded H. pylori colonies did not merge and left gaps. The basis of these gaps was unknown. We report here that gap formation was not affected by media components such as nutrient and agar concentrations, nor did it require chemotaxis, but it did rely on quorum sensing. To broaden our understanding of this H. pylori property, an H. pylori Tn7 transposon library was screened for mutants that lost gap formation. Fourteen mutants were identified, with transposon sites mapped to genes encoding outer membrane proteins, cysteine-rich proteins, phosphatidyl glycerophosphate synthase, an endorestriction nuclease, and several hypothetical proteins. Our results suggest that H. pylori may use specific proteins to avoid contact with other H. pylori, a behavior that may relate to previous observations that different H. pylori strains do not mix populations in stomach glands.

28 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YEYasmine O Elshenawi
Yasmine O Elshenawi
SHSkander Hathroubi
Skander Hathroubi
ALAngela E. Lane
Angela E. Lane
MHMegan Hetzel
Megan Hetzel
KOKaren M. Ottemann
Karen M. Ottemann
Helicobacter pylori is a prevalent bacterial pathogen that chronically colonizes the human gastric epithelium, but the bacterium's physiological mechanisms that promote chronic colonization are understudied. Dormancy and low growth are known to facilitate other microbial chronic infections. A critical feature of low growth states is the down regulation of ribosome translational activity via regulation factors. The H. pylori genome is predicted to encode only one ribosome regulation factor, called RsfS (Ribosomal Silencing Factor S). In other bacterial species, RsfS prevents ribosome assembly by binding to a protein called L14 on the 50S large ribosomal subunit. Although H. pylori RsfS has not been experimentally investigated prior to this work, it conserves key residues, suggesting it is a bona fide RsfS homolog. To investigate phenotypes associated with rsfS, the gene was deleted and mutant phenotypes characterized. H. pylori rsfS null mutants had no defects during exponential phase but had viability defects in stationary phase and low growth factor conditions. Additionally, rsfS null mutants could not form biofilms, and instead were only able to form monolayers of multicellular aggregates. These defects were corrected by the re-introduction of rsfS in a second site on the chromosome. To explore whether rsfS is required in vivo, a mouse model was employed. rsfS mutants initially colonized in low numbers in both the glands and total stomach but were unable to develop robust long-term colonization. This work supports that H. pylori requires RsfS for survival in low growth states and to maintain chronic infections in the host.

2 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
YEYasmine O Elshenawi
Yasmine O Elshenawi
SHSkander Hathroubi
Skander Hathroubi
SHShuai Hu
Shuai Hu
Xiaolin LiuXiaolin Liu
Xiaolin Liu
KOKaren M. Ottemann
Karen M. Ottemann
Helicobacter pylori is a motile bacterial pathogen that causes severe gastric diseases globally. H. pylori motility and chemotaxis are key colonization factors. Motility and chemotaxis are studied in many microbes, including H. pylori, using soft agar assays. In these assays, bacteria are inoculated into low-percentage agar and expand in a motility and chemotaxis-dependent manner. H. pylori similarly expand in soft agar but if a plate is inoculated at multiple points, the expanded H. pylori colonies do not merge and leave gaps. The basis of these gaps was unknown. We report here that gap formation was not affected by media components such as nutrient and agar concentrations, nor did it require chemotaxis but did rely on quorum sensing. To broaden our understanding of this H. pylori property, an H. pylori Tn7 transposon library was screened for mutants that lost gap formation. Fourteen mutants were obtained, and the transposon sites mapped to genes encoding outer membrane proteins, cysteine rich proteins, phosphatidyl glycerophosphate synthase, an endorestriction nuclease and several hypothetical proteins. Our results suggest that H. pylori may use specific proteins to avoid contact with other H. pylori, a behavior that may relate to previous observations that different H. pylori strains do not mix populations in stomach glands.

12 November 2026 in Infection and Immunity
Verified
Journal Article
Open access
YEYasmine O Elshenawi
Yasmine O Elshenawi
MYMee-Ngan F. Yap
Mee-Ngan F. Yap
KOKaren M. Ottemann
Karen M. Ottemann
Ribosomes are essential macromolecules that convert mRNA to polypeptides. Ribosomes can be regulated by multiple mechanisms, including limiting the biogenesis of ribosomal subunits, sequestering 70S ribosomes, dimerizing 70S complexes into inactive 100S ribosomes, and “silencing” the 50S subunit to prevent the assembly of active 70S ribosomes. In this review, we focus on the protein that carries out ribosomal silencing, called ribosomal silencing factor S (RsfS), that has been shown in multiple species to bind to the uL14 ribosomal protein in the 50S subunit and prevent 50S-to-30S subunit joining. RsfS is a highly conserved small protein found across most bacterial species and in eukaryotes. The direct target of RsfS, uL14 ( rplN ), is one of the most conserved ribosomal proteins. RsfS has been primarily studied for binding interactions with uL14 and the downstream effects of preventing 70S ribosome assembly. rsfS null mutant strains exhibit defects in several bacterial species in vitro (stationary phase, biofilm, growth, nutrient limitation, and oxidative stress) and in vivo (macrophage and murine models). However, other topics remain underexplored, highlighting areas for future study, such as the regulation of RsfS and uL14 expression, additional roles in antibiotic tolerance, whether RsfS has physiological roles beyond ribosomal silencing, and if other factors dictate ribosomal interactions. Overall, while RsfS is clearly important in many bacteria, there remain many areas for future studies.